Skip to content

Ectopic Pregnancy Biomarkers

Serum Bank for Assessment of Markers of Ectopic Pregnancy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00194168
Enrollment
1306
Registered
2005-09-19
Start date
2000-06-30
Completion date
2013-11-30
Last updated
2016-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic Pregnancy

Keywords

ectopic pregnancy

Brief summary

In an attempt to simplify the diagnosis of ectopic pregnancy, the researchers will investigate the presence of specific molecular markers of ectopic pregnancy. The quantification of these (and other proteins) will be performed using the Ciphergen Protein Chip system where serum is sampled with a high-throughput system. The patterns of these peaks will be compared for those with a diagnosis of ectopic pregnancy and normal pregnancy. Later goals of the research will be to identify the actual proteins that correspond to the peaks which discriminate between the two clinical entitles. The goal is to identify a unique protein pattern or protein peak to distinguish a normal intrauterine pregnancy from that of an ectopic implanted gestation.

Interventions

None listed

Sponsors

Bill and Melinda Gates Foundation
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Reproductive-aged women * Currently pregnant based on serum human chorionic gonadotropin level * Present for care for pregnancy due to vaginal bleeding and/or pelvic cramping * Final diagnosis of one of the following: 1. Live intrauterine pregnancy through 14 weeks, diagnosed by ultrasound demonstrating fetal heart motion 2. Diagnosed ectopic pregnancy 3. Ultrasound confirmation of a nonviable gestation (less 14 weeks) such as an anembryonic gestation or a fetal demise

Exclusion criteria

* None

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026